Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/2010
07/14/2010EP2205579A1 Compounds of 2,3-dihydro-benzofuran
07/14/2010EP2205575A1 A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
07/14/2010EP2205573A1 Tetrazole-substituted aryl amide derivatives and uses thereof
07/14/2010EP2205568A1 6-aryl/heteroalkyloxy benzothiazole and benzimidazole derivatives, method for preparing same, application thereof as drugs, pharmaceutical compositions and novel use in particular as c-met inhibitors
07/14/2010EP2205567A1 Gamma secretase modulators
07/14/2010EP2205560A1 Azabicyclo ý3. 1. 0¨hexyl derivatives as modulators of dopamine d3 receptors
07/14/2010EP2205558A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators
07/14/2010EP2205317A1 Pyridine derivatives for the treatment of amyloid-related diseases
07/14/2010EP2205245A1 Therapeutic use of diaminophenothiazines
07/14/2010EP2205238A2 Combination therapy related to serotonin dual action compounds
07/14/2010EP2205229A1 Compounds and methods for pharmaceutical use
07/14/2010EP1824830B1 Radiolabelled quinoline-based ligands for the 5-ht6 receptor functionality
07/14/2010EP1778236B1 Modified pyrimidine glucocorticoid receptor modulators
07/14/2010EP1699778B1 (4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics
07/14/2010EP1689721B1 Aminopyrazole derivatives as gsk-3 inhibitors
07/14/2010EP1648443B1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands
07/14/2010EP1337655B1 Lentiviral vectors for the treatment of neurodegenerative diseases
07/14/2010CN201523905U Hypnosis medicine pillow
07/14/2010CN1955179B [1,4]diazepino[6,7,1-IJ]quinoline derivatives as antipsychotic and antiobesity agents
07/14/2010CN1935235B Chinese medicine injection preparation and its preparing method
07/14/2010CN1911102B Compounding agent for sobering and health-care, and its production method
07/14/2010CN101778848A Naphthyridine derivatives as potassium channel modulators
07/14/2010CN101778846A 1,2-diamido-ethylene derivatives as orexin antagonists
07/14/2010CN101778838A Azacyclylbenzamide derivatives as histamine-3 antagonists
07/14/2010CN101778826A Azepine derivatives as gamma-secretase inhibitors
07/14/2010CN101778640A antibody formulations
07/14/2010CN101778634A Pirenzepine and derivatives thereof as anti-amyloid agents
07/14/2010CN101778632A Remedy or preventive for integration dysfunction syndrome
07/14/2010CN101778631A Method for producing pharmaceutical tablet
07/14/2010CN101778628A Methods for treating anxiety
07/14/2010CN101775072A Glial cell line-Derived Neurotrophic Factor (GDNF) fusing penetrating peptides
07/14/2010CN101774937A N-[2-(7-methoxyl-1-naphthyl)ethyl]acetamide and compound thereof
07/14/2010CN101774922A 2,3-dyhydroxyl parabens compound as well as preparation and application thereof
07/14/2010CN101773652A Chinese medicine composition for treating amnesia and preparation method thereof
07/14/2010CN101773651A Chinese medicine composition for treating headache and preparation method thereof
07/14/2010CN101773650A Chinese medicinal composition for treating clonic convulsion and preparation method thereof
07/14/2010CN101773644A Traditional Chinese medicine for moxa treatment of neurodynia after paraplegia
07/14/2010CN101773641A Chinese medicine composition preparation for liver soothing and depression relief and quality control method
07/14/2010CN101773639A Drug for treatment of Parkinson disease
07/14/2010CN101773638A Drug for treatment of Parkinson disease
07/14/2010CN101773635A Medicament for treating epilepsy
07/14/2010CN101773632A Chinese medicine composition for treating dizziness and preparation method thereof
07/14/2010CN101773606A Preparation capable of nursing essence, replenishing qi, refreshing spirit and balancing yin and yang and preparation method thereof
07/14/2010CN101773585A Chinese medicine for treating facial paralysis
07/14/2010CN101773571A Preparation process of blood activating capsule
07/14/2010CN101773570A Medicine for treating headache
07/14/2010CN101773563A Medicine composition
07/14/2010CN101773559A Chinese medicine preparation for treating insomnia
07/14/2010CN101773540A Chinese medicine for treating neurasthenia
07/14/2010CN101773523A Traditional Chinese medicine antimanic drug for treatment of hyperlipemia and preparation thereof
07/14/2010CN101773494A New application of green tea polyphenol
07/14/2010CN101773493A New application of medicine compound brazilein
07/14/2010CN101773488A Medicament based on rosmarinic acid and application thereof in treating Parkinson's disease
07/14/2010CN101773475A Preparation method of capsicine micro spheres
07/14/2010CN101773463A Selenium-enriched nano pearl powder formula and production method thereof
07/14/2010CN101773349A Anion multifunctional pillow
07/14/2010CN101773291A Mixed cigarette
07/14/2010CN101244244B Depression treating medicine composition and preparation method thereof
07/14/2010CN101181592B Chinese medicine for curing intractable headache and sick headache
07/14/2010CN101002844B Instant granulated medicine for sobering use and its preparing method
07/13/2010USRE41439 Pharmaceutical compositions and methods for use
07/13/2010US7756643 Method for determining the biological effect and/or activity of at least one drug, chemical substances and/or pharmaceutical composition based on their effect on the methylation status of DNA
07/13/2010US7754856 Human sodium-dependent bile acid transporter proteins
07/13/2010US7754855 comprising a full-length human erythropoietin protein joined without an intervening peptide linker to a human immunoglobulin domain; making fusion proteins comprising a cytokine or growth factor fused to an immunoglobulin domain; treating deficient hematocrit; purification
07/13/2010US7754772 (2R)-2,3-bis(nitrooxy)propyl(2S)-2(6-methoxy(2-naphthyl)propanoate, used for treating inflammation, pain and fever; gastrointestinal disorders; wound healing agents; preventing gastrointestinal, renal and/or respiratory toxicities; side effect reduction
07/13/2010US7754754 benzo[b]furan-2-yl-(3,5-dichlorophenylamino)acetic acid, benzo[b]thiophen-2-yl-(3,5-dichlorophenylamino)acetic acid, for example; for combatting pain, preferably chronic and/or neuropathic pain, and which preferably do not exhibit the undesired accompanying symptoms which occur with opioids
07/13/2010US7754753 Potentiating an NSAID and/or acetaminophen analgesic by administering concurrently a cyclooxygenase-2 inhibitor such as celecoxib, meloxicam, nimesulide and/or rofecoxib
07/13/2010US7754751 Preferential inhibition of release of pro-inflammatory cytokines
07/13/2010US7754750 a -5 substituted 1-H,3-H-imidazolidine-2,4-dione such as 5-(2-{[4-(4'-fluoro[1,1'-biphenyl]-4-yl)-1-piperazinyl]sulfonyl}ethyl)-2,4-imidazolidinedione; protease inhibitors, especially metalloelastase (MMP12)
07/13/2010US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
07/13/2010US7754732 such as 4-Oxo-2-phenyl-1,3,8-triaza-spiro[4,5]dec-1-ene-8-carboxylic acid{1-7-methyl-1H-indazol-5-yl methyl)-2-[1,4]bipiperidinyl-1'-yl-2-oxo-ethyl}-amide, used as antagonists of calcitonin gene-related peptide receptors; used in the therapy of headaches and respiratory system disorders
07/13/2010US7754712 11-(4-Chloro-benzenesulfonyl)-4,5,11-triaza-tricyclo[6.2.1.02,6]undeca-2(6),3-diene; inhibit beta-amyloid peptide release or its synthesis; secretases inhibitor; neurodegenerative and neurological diseases: Alzheimer's, Parkinson's diseases, Down's syndrome, degenerative dementias
07/13/2010US7754708 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof
07/13/2010US7754250 Drugs comprising plant extracts used for prevention amyloid formation, deposition or accumulation; amyloid fibrils, amylin fibrils, or islet amyloid fibrils or pre-deposited amyloid fibrils in type II diabetes; amyloid inhibitor
07/13/2010US7754240 Solid at ambient temperature, softening point of </= 35 degrees C., when placed in continuous contact with skin it is softened to a consistency so substantial application of the unit dose is delivered in < 10 minutes
07/13/2010US7754236 polyester-based film substrate have specified surface roughness on the side that a drug-containing adhesive layer is laminated thereon; free from any migration of a drug into a substrate; bonding strength, no adhesive residue when peeled off skin; for narcotic analgesic fentanyl
07/13/2010US7754228 Cytotoxic T-cell epitopes from Chlamydia
07/13/2010US7754190 Neurophysiological information from quantitative electroencephalogram (QEEG) is used as the independent variable and medication response is analyzed as the dependent variable; observing the connection between neurophysiology and the clinical outcome of treatment; pharmakinetics
07/13/2010US7753054 Method of constructing spinal injury model monkey and utilization thereof
07/13/2010CA2557536C Amino alcohol compound
07/13/2010CA2505910C Imidazoquinoline derivatives as adenosine a3 receptor ligands
07/13/2010CA2500888C Isoquinoline compounds and medicinal use thereof
07/13/2010CA2457451C Naphthyridine derivatives
07/13/2010CA2449163C New use of 2-phenyl-substituted imidazotriazinones
07/13/2010CA2446820C Novel pyrrole derivatives as pharmaceutical agents
07/13/2010CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
07/13/2010CA2443135C Pharmaceutically active compounds and methods of use
07/13/2010CA2430539C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
07/13/2010CA2409697C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/13/2010CA2374659C N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and agents for treating neurodegenerative diseases comprising the same
07/13/2010CA2347713C Contulakin-g, analogs thereof and uses therefor
07/13/2010CA2304970C Method and reagents for n-alkylating ureides
07/08/2010WO2010078307A1 Spiro-oxindole-derivatives as sodium channel blockers
07/08/2010WO2010077992A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
07/08/2010WO2010077988A2 Role of proline rich peptides in cellular communication mechanisms and treatment of diseases
07/08/2010WO2010077852A2 Method of inducing cleavage of amyloid precursor protein to form a novel fragment
07/08/2010WO2010077839A1 Substituted oxindol cb2 agonists for pain treatment
07/08/2010WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010WO2010077364A2 Stroke-generated angiogenesis enhancers and uses thereof
07/08/2010WO2010076418A1 Novel oxime derivatives of 3,5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
1 ... 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 ... 1833